Cite
Calpain Inhibitor Calpeptin Improves Alzheimer's Disease–Like Cognitive Impairments and Pathologies in a Diabetes Mellitus Rat Model.
MLA
Li, Min, et al. “Calpain Inhibitor Calpeptin Improves Alzheimer’s Disease–Like Cognitive Impairments and Pathologies in a Diabetes Mellitus Rat Model.” Neurotoxicity Research, vol. 40, no. 5, Oct. 2022, pp. 1248–60. EBSCOhost, https://doi.org/10.1007/s12640-022-00561-z.
APA
Li, M., Zhou, S., Wang, G., Qiao, L., Yi, S., Li, T., Pan, X., Liu, X., & Tang, Z. (2022). Calpain Inhibitor Calpeptin Improves Alzheimer’s Disease–Like Cognitive Impairments and Pathologies in a Diabetes Mellitus Rat Model. Neurotoxicity Research, 40(5), 1248–1260. https://doi.org/10.1007/s12640-022-00561-z
Chicago
Li, Min, Siqi Zhou, Gege Wang, Luyao Qiao, Shouqin Yi, Tianpei Li, Xin Pan, Xu Liu, and Zhenyu Tang. 2022. “Calpain Inhibitor Calpeptin Improves Alzheimer’s Disease–Like Cognitive Impairments and Pathologies in a Diabetes Mellitus Rat Model.” Neurotoxicity Research 40 (5): 1248–60. doi:10.1007/s12640-022-00561-z.